Please enable JavaScript to experience the full functionality of mail.com.

European Medicines Agency recommends licensing Ebola vaccine

LONDON (AP) — The European Medicines Agency has recommended that the world's first Ebola vaccine be approved, after it was administered to hundreds of thousands of people in Africa. The agency on Friday described licensing the vaccine as "an important step toward relieving the burden of this deadly disease." The Ebola vaccine was originally developed in Canada and is now marketed by Merck as Ervebo. More than 270,000 people in Africa have received it as officials try to stop Congo's ongoing outbreak.

Sponsored Content